Development of a drug delivery system for the inner ear using poly(amino acid)-based nanoparticles

Drug Delivery

Volumn 22, Issue 3, 2015, Pages 367-374

  Kim, Dong Kee ^a   Park, Shi Nae ^a   Park, Kyoung Ho ^a   Park, Chan Woo ^b   Yang, Keum Jin ^c   Kim, Jong Duk ^b   Kim, Min Sik ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Daejeon St Mary's Hospital   (South Korea)

Author keywords

Confocal microscopy; Drug delivery; Hearing loss; Inner ear; Polymersome

Indexed keywords

ALCOHOL; DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE; NANOPARTICLE; POLY(2 HYDROXYETHYL ASPARTAMIDE) POLYMERSOME; POLYMER; UNCLASSIFIED DRUG; ALPHA,BETA-POLY((2-HYDROXYETHYL)-ASPARTAMIDE); PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCHLEA; COCHLEA FENESTRA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORTI ORGAN; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DRUG DELIVERY SYSTEM; HEARING TEST; HISTOLOGY; INNER EAR; INNER HAIR CELL; MALE; MIDDLE EAR; MIDDLE EAR MUCOSA; MOUSE; NONHUMAN; OUTER HAIR CELL; PERMEABILITY; PRIORITY JOURNAL; SAFETY; ZETA POTENTIAL; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; METABOLISM; PROCEDURES; TISSUE DISTRIBUTION;

ANIMALS; COCHLEA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EAR, INNER; HEARING TESTS; MALE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; NANOPARTICLES; PEPTIDES; PERMEABILITY; TISSUE DISTRIBUTION;

EID: 84930456928     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.879354     Document Type: Article

References (23)

1. Chen G, Zhang X, Yang F, Mu L. (2010). Disposition of nanoparticlebased Delivery system via inner ear administration. Curr Drug Metab 11:886-97
2. Discher BM, Won YY, Ege DS, et al. (1999). Polymersomes: tough vesicles maDe from diblock copolymers. Science 284:1143-6
3. Gelperina S, Kisich K, Iseman MD, Heifets L. (2005). The potential advantages of nanoparticle drug Delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 172:1487-90
4. Goycoolea MV. (2001). Clinical aspects of round window membrane permeability unDer normal and pathological conditions. Acta Otolaryngol 121:437-47
5. Guzman LA, Labhasetwar V, Song C, et al. (1996). Local intraluminal infusion of bioDegradable polymeric nanoparticles. A novel approach for prolonged drug Delivery after balloon angioplasty. Circulation 94: 1441-8
6. Juhn SK, Rybak LP, Fowlks WL. (1982). Transport characteristics of the blood-perilymph barrier. Am J Otolaryngol 3:392-6
7. Kang H, Kim JD, Han SH, Chang IS. (2002). Self-aggregates of poly(2-hydroxyethyl aspartamiDe) copolymers loaDed with methotrexate by physical and chemical entrapments. J Control Release 81:135-44
8. McCall AA, Swan EE, Borenstein JT, et al. (2010). Drug Delivery for treatment of inner ear disease: current state of knowledge. Ear Hear 31:156-65
9. Moss OR, Wong VA. (2006). When nanoparticles get in the way: impact of projected area on in vivo and in vitro macrophage function. Inhal Toxicol 18:711-16
10. Park SN, Back SA, Choung YH, et al. (2011). alpha-Synuclein Deficiency and efferent nerve Degeneration in the mouse cochlea: a possible cause of early-onset presbycusis. Neurosci Res 71:303-10
11. Parnes LS, Sun AH, Freeman DJ. (1999). Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109:1-17
12. Pyykko I, Zou J, Zhang W, Zhang Y. (2011). Nanoparticle-based Delivery for the treatment of inner ear disorDers. Curr Opin Otolaryngol Head Neck Surg 19:388-96
13. Rask-AnDersen H, Schrott-Fischer A, Pfaller K, Glueckert R. (2006). Perilymph/modiolar communication routes in the human cochlea. Ear Hear 27:457-65
14. Roy S, Johnston AH, Newman TA, et al. (2010). Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-Derived peptiDe ligand: potential tool for drug Delivery. Int J Pharm 390:214-24
15. Sajjadi H, Paparella MM. (2008). Menieres disease. Lancet 372: 406-14
16. Salt AN, King EB, Hartsock JJ, et al. (2012). Marker entry into vestibular perilymph via the stapes following applications to the round window niche of guinea pigs. Hear Res 283:14-23
17. Slattery WH, Fisher LM, Iqbal Z, et al. (2005). Intratympanic steroid injection for treatment of idiopathic sudDen hearing loss. Otolaryngol Head Neck Surg 133:251-9
18. Surovtseva EV, Johnston AH, Zhang W, et al. (2012). Prestin binding peptiDes as ligands for targeted polymersome mediated drug Delivery to outer hair cells in the inner ear. Int J Pharm 424:121-7
19. Yang SR, Kim SB, Joe CO, Kim JD. (2008). Intracellular Delivery enhancement of poly(amino acid) drug carriers by oligoarginine conjugation. J Biomed Mater Res A 86:137-48
20. Yokoyama M, Miyauchi M, Yamada N, et al. (1990). Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res 50:1693-700
21. Zhang Y, Zhang W, Johnston AH, et al. (2010). Improving the visualization of fluorescently tagged nanoparticles and fluorophore-labeled molecular probes by treatment with CuSO(4) to quench autofluorescence in the rat inner ear. Hear Res 269: 1-11
22. Zhang Y, Zhang W, Lobler M, et al. (2011). Inner ear biocompatibility of lipid nanocapsules after round window membrane application. Int J Pharm 404:211-19
23. Zou J, Sood R, Ranjan S, et al. (2010). Manufacturing and in vivo inner ear visualization of MRI traceable liposome nanoparticles encapsulating gadolinium. J Nanobiotechnol 8:32